REVO-UWD-19 universal CAR-T cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for REVO-UWD-19 universal CAR-T cells, covering 2026-01-20 to 2026-01-20. Get the full timeline:
Most recent: Clinical Trial Update: Universal CAR-T Cells (REVO-UWD-19) for Refractory and Relapsed B-Cell Tumors [EARLY_Phase 1]